Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$50.12 - $58.87 $143,994 - $169,133
2,873 Added 1.4%
207,560 $11 Million
Q2 2023

Aug 14, 2023

BUY
$42.28 - $51.43 $974,004 - $1.18 Million
23,037 Added 12.68%
204,687 $10.5 Million
Q1 2023

May 15, 2023

SELL
$40.84 - $58.14 $614,846 - $875,297
-15,055 Reduced 7.65%
181,650 $7.92 Million
Q4 2022

Feb 14, 2023

SELL
$43.88 - $56.16 $694,049 - $888,282
-15,817 Reduced 7.44%
196,705 $10.9 Million
Q3 2022

Nov 14, 2022

SELL
$48.37 - $66.5 $93,499 - $128,544
-1,933 Reduced 0.9%
212,522 $10.8 Million
Q2 2022

Aug 15, 2022

SELL
$57.25 - $86.63 $323,691 - $489,806
-5,654 Reduced 2.57%
214,455 $13.4 Million
Q1 2022

May 16, 2022

SELL
$71.02 - $86.99 $1.85 Million - $2.26 Million
-25,988 Reduced 10.56%
220,109 $18 Million
Q4 2021

Feb 14, 2022

SELL
$76.72 - $92.68 $1.11 Million - $1.34 Million
-14,512 Reduced 5.57%
246,097 $21.5 Million
Q3 2021

Nov 15, 2021

SELL
$76.02 - $88.62 $568,857 - $663,143
-7,483 Reduced 2.79%
260,609 $20.6 Million
Q2 2021

Aug 16, 2021

SELL
$73.44 - $87.01 $683,946 - $810,324
-9,313 Reduced 3.36%
268,092 $22.5 Million
Q1 2021

May 14, 2021

BUY
$62.9 - $82.41 $634,723 - $831,599
10,091 Added 3.77%
277,405 $20.5 Million
Q4 2020

Feb 16, 2021

SELL
$46.01 - $68.74 $871,521 - $1.3 Million
-18,942 Reduced 6.62%
267,314 $17.7 Million
Q3 2020

Nov 13, 2020

SELL
$41.91 - $57.81 $726,928 - $1 Million
-17,345 Reduced 5.71%
286,256 $12.9 Million
Q2 2020

Aug 14, 2020

SELL
$39.87 - $56.9 $230,129 - $328,426
-5,772 Reduced 1.87%
303,601 $14.6 Million
Q1 2020

May 15, 2020

BUY
$34.22 - $76.49 $3.14 Million - $7.01 Million
91,673 Added 42.11%
309,373 $14 Million
Q4 2019

Feb 14, 2020

BUY
$68.92 - $85.27 $15 Million - $18.6 Million
217,700 New
217,700 $16.4 Million

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.5B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track London CO Of Virginia Portfolio

Follow London CO Of Virginia and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of London CO Of Virginia, based on Form 13F filings with the SEC.

News

Stay updated on London CO Of Virginia with notifications on news.